72 related articles for article (PubMed ID: 6665015)
21. Divergent anatomical pattern of D1 and D3 binding and dopamine- and cyclic AMP-regulated phosphoprotein of 32 kDa mRNA expression in the Roman rat strains: Implications for drug addiction.
Guitart-Masip M; Johansson B; Fernández-Teruel A; Cañete T; Tobeña A; Terenius L; Giménez-Llort L
Neuroscience; 2006 Nov; 142(4):1231-43. PubMed ID: 17008016
[TBL] [Abstract][Full Text] [Related]
22. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological profile of the dopamine partial agonist, (+/-)-PD 128483 and its enantiomers.
Meltzer LT; Caprathe BW; Christoffersen CL; Corbin AE; Jaen JC; Ninteman FW; Pugsley TA; Serpa KA; Shih YH; Whetzel SZ
J Pharmacol Exp Ther; 1993 Sep; 266(3):1177-89. PubMed ID: 8103791
[TBL] [Abstract][Full Text] [Related]
24. Role of striatal dopaminergic receptors in amphetamine-induced behavioral facilitation.
Conway PG; Uretsky NJ
J Pharmacol Exp Ther; 1982 Jun; 221(3):650-5. PubMed ID: 7201019
[No Abstract] [Full Text] [Related]
25. Stimulation of postsynaptic alpha1b- and alpha2-adrenergic receptors amplifies dopamine-mediated locomotor activity in both rats and mice.
Villégier AS; Drouin C; Bizot JC; Marien M; Glowinski J; Colpaërt F; Tassin JP
Synapse; 2003 Dec; 50(4):277-84. PubMed ID: 14556232
[TBL] [Abstract][Full Text] [Related]
26. Reverse tolerance to the ambulation-increasing effect of methamphetamine in mice as an animal model of amphetamine-psychosis.
Tadokoro S; Kuribara H
Psychopharmacol Bull; 1986; 22(3):757-62. PubMed ID: 3797581
[No Abstract] [Full Text] [Related]
27. Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine.
Dietz DM; Tapocik J; Gaval-Cruz M; Kabbaj M
Physiol Behav; 2005 Oct; 86(3):347-55. PubMed ID: 16126238
[TBL] [Abstract][Full Text] [Related]
28. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine.
Pierce RC; Kalivas PW
J Pharmacol Exp Ther; 1995 Nov; 275(2):1019-29. PubMed ID: 7473128
[TBL] [Abstract][Full Text] [Related]
29. Motor activity and gene expression in rats with neonatal 6-hydroxydopamine lesions.
Masuo Y; Ishido M; Morita M; Oka S; Niki E
J Neurochem; 2004 Oct; 91(1):9-19. PubMed ID: 15379882
[TBL] [Abstract][Full Text] [Related]
30. Adult mice with reduced Nurr1 expression: an animal model for schizophrenia.
Rojas P; Joodmardi E; Hong Y; Perlmann T; Ogren SO
Mol Psychiatry; 2007 Aug; 12(8):756-66. PubMed ID: 17457314
[TBL] [Abstract][Full Text] [Related]
31. A neural substrate of hyperactivity in borna disease: changes in brain dopamine receptors.
Solbrig MV; Koob GF; Joyce JN; Lipkin WI
Virology; 1996 Aug; 222(2):332-8. PubMed ID: 8806517
[TBL] [Abstract][Full Text] [Related]
32. [Role of adreno- and dopamine-reactive systems in the central action of caffeine].
Kurbat NM; Korablev MV
Farmakol Toksikol; 1981; 44(5):559-61. PubMed ID: 7198054
[No Abstract] [Full Text] [Related]
33. The hyperkinetic child syndrome and brain monoamines: pharmacology and therapeutic implications.
Margolin DI
J Clin Psychiatry; 1978 Feb; 39(2):120-3, 7-30. PubMed ID: 344302
[TBL] [Abstract][Full Text] [Related]
34. [Species differences in the effects of apomorphine as an adrenergic agent].
Lapin IP; Samsonova ML
Biull Eksp Biol Med; 1968 Dec; 66(12):63-5. PubMed ID: 5754755
[No Abstract] [Full Text] [Related]
35. A dopaminergic basis for the effects of amphetamine on a mouse "preadolescent hyperkinetic" model.
Alpern HP; Greer CA
Life Sci; 1977 Jul; 21(1):93-8. PubMed ID: 560611
[No Abstract] [Full Text] [Related]
36. [Jactstio capitis--motor stereotypy in rodents].
Kolpakov VG; Barykina NN; Borodin PM; Serova LI
Genetika; 1976; 12(1):71-7. PubMed ID: 944671
[TBL] [Abstract][Full Text] [Related]
37. [Relation of the anorexigenic, hyperthermal, and excitomotor activity of compounds structurally related to amphentamine].
Riva M; Kabir Naimzada M; Pirola C; Mantegazza P
Farmaco Sci; 1969 Feb; 24(2):238-48. PubMed ID: 5786384
[No Abstract] [Full Text] [Related]
38. Studies of the hyperkinetic syndrome -- Part I. An experimental analysis.
Wray SR; Egbe P
West Indian Med J; 1975 Sep; 24(3):160-4. PubMed ID: 1239867
[No Abstract] [Full Text] [Related]
39. Genetic aspects of dopamine receptor binding in the mouse and rat brain: an overview.
Vadasz C; Laszlovszky I; De Simone PA; Fleischer A
J Neurochem; 1992 Sep; 59(3):793-808. PubMed ID: 1494909
[No Abstract] [Full Text] [Related]
40. Effect of amphetamines in hyperkinetic children: stimulant of sedative? A pilot study.
Montagu JD; Swarbrick L
Dev Med Child Neurol; 1975 Jun; 17(3):293-8. PubMed ID: 1204982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
